Results 181 to 190 of about 190,792 (295)

Engineering hope: tissue-engineered intestine as a breakthrough for pediatric short bowel syndrome. [PDF]

Ann Med Surg (Lond)
Khan A, Khalid M, Talha M, Waafira A.
europepmc   +1 more source

Self-reported sleep disturbance in Crohn’s disease is not confrmed by objective sleep measures [PDF]

, 2020
Ciorba, Matthew A., Gyawali, C. Prakash, Iskandar, Heba N., Lasanajak, Yi, Linan, Emily E., Moore, Renee, Patel, Ami, Sayuk, Gregory S.   +7 more
core   +1 more source

Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects

Cancer Nexus, EarlyView.
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han, Ying Wang, Xintao Gao, Yan Lei, Yantao Li, Zhiyong Tang   +5 more
wiley   +1 more source

Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study. [PDF]

J Clin Med
Parisio L, Del Gaudio A, Iaccarino J, Puca P, Becherucci G, Coppola G, Covello C, Vincenzo FD, Foscarini E, Laterza L, Masi L, Pizzoferrato M, Profeta F, Pugliese D, Petito V, Chieppa M, Mocci G, Cammarota G, Gasbarrini A, Lopetuso LR, Covino M, Scaldaferri F, Papa A.   +22 more
europepmc   +1 more source

Intestinal and multiple organ transplantation [PDF]

, 2005
Abu-Elmagd, K, Mazariegos, G, Reyes, J, Starzl, TE   +3 more
core  

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, EarlyView.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Safety of Teduglutide for Managing Patients with Short Bowel Syndrome: A Systematic Review and Meta-analysis. [PDF]

Pak J Med Sci
Liu S, Yu X, Ye F, Jiang L.
europepmc   +1 more source

Pss knockdown in the midgut causes growth retardation in Drosophila similar to that in human LMHD

Developmental Dynamics, EarlyView.
Abstract Background Phosphatidylserine synthase (PSS), localized in the mitochondrial membrane, synthesizes phosphatidylserine. In humans, mutations in Pss lead to Lenz–Majewski hyperostotic dwarfism, a disorder affecting growth and development. The effects of Pss mutations on the growth of Drosophila melanogaster are not fully known. Hence, this study
Kwan‐Young Kim, You‐Lim Hwang, Sunwoo Yeom, Seung‐Hae Kwon, Sang‐Hak Jeon   +4 more
wiley   +1 more source

Remodelling the Colon With Ileal Properties to Treat Short Bowel Syndrome. [PDF]

Gastroenterology
Liu T, Li S, Múnera JO, Shivdasani RA, Huang X, Zhou Q.   +5 more
europepmc   +1 more source